These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 35029348)
1. Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions and Culprit Drugs. de Groot AC Dermatitis; 2022 Jan-Feb 01; 33(1):16-30. PubMed ID: 35029348 [TBL] [Abstract][Full Text] [Related]
2. Clindamycin-induced Maculopapular Exanthema with Preferential Involvement of Striae Distensae: A Koebner phenomenon? Monteagudo B; Cabanillas M; Iriarte P; Ramírez-Santos A; León-Muinos E; González-Vilas D; Suárez-Amor Ó Acta Dermatovenerol Croat; 2018 Apr; 26(1):61-63. PubMed ID: 29782303 [TBL] [Abstract][Full Text] [Related]
3. Utility of patch testing for the diagnosis of delayed-type drug hypersensitivity reactions to clindamycin. Gilissen L; Huygens S; Goossens A; Breynaert C; Schrijvers R Contact Dermatitis; 2020 Sep; 83(3):237-239. PubMed ID: 32333605 [No Abstract] [Full Text] [Related]
4. The use of patch tests in the diagnosis of delayed hypersensitivity drug eruptions. Hassoun-Kheir N; Bergman R; Weltfriend S Int J Dermatol; 2016 Nov; 55(11):1219-1224. PubMed ID: 27368159 [TBL] [Abstract][Full Text] [Related]
5. [Drug patch tests in the investigation of cutaneous adverse drug reactions]. Barbaud A Ann Dermatol Venereol; 2009; 136(8-9):635-44. PubMed ID: 19686903 [TBL] [Abstract][Full Text] [Related]
6. Generalized reactions during skin testing with clindamycin in drug hypersensitivity: a report of 3 cases and review of the literature. Papakonstantinou E; Müller S; Röhrbein JH; Wieczorek D; Kapp A; Jakob T; Wedi B Contact Dermatitis; 2018 Apr; 78(4):274-280. PubMed ID: 29356000 [TBL] [Abstract][Full Text] [Related]
7. Value of patch tests in clindamycin-related drug eruptions. Pereira N; Canelas MM; Santiago F; Brites MM; Gonçalo M Contact Dermatitis; 2011 Oct; 65(4):202-7. PubMed ID: 21689110 [TBL] [Abstract][Full Text] [Related]
8. [DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS]. Bensaïd B; Valeyrie-Allanore L; Lebrun-Vignes B; Nicolas JF Rev Prat; 2015 Sep; 65(7):981-5. PubMed ID: 26619740 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of skin test reactions in patients with non-immediate type drug eruptions. Osawa J; Naito S; Aihara M; Kitamura K; Ikezawa Z; Nakajima H J Dermatol; 1990 Apr; 17(4):235-9. PubMed ID: 2142173 [TBL] [Abstract][Full Text] [Related]
10. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions. Winnicki M; Shear NH Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762 [TBL] [Abstract][Full Text] [Related]
11. Severe cutaneous adverse reactions to drugs. Duong TA; Valeyrie-Allanore L; Wolkenstein P; Chosidow O Lancet; 2017 Oct; 390(10106):1996-2011. PubMed ID: 28476287 [TBL] [Abstract][Full Text] [Related]
12. [Drug reaction with eosinophilia and systemic symptoms]. Tehrany YA; Laffitte E; Grosgurin O; Spoerl D Rev Med Suisse; 2016 Apr; 12(513):684-6, 688-90. PubMed ID: 27197323 [TBL] [Abstract][Full Text] [Related]
13. The use of skin testing in the investigation of cutaneous adverse drug reactions. Barbaud A; Reichert-Penetrat S; Tréchot P; Jacquin-Petit MA; Ehlinger A; Noirez V; Faure GC; Schmutz JL; Béné MC Br J Dermatol; 1998 Jul; 139(1):49-58. PubMed ID: 9764148 [TBL] [Abstract][Full Text] [Related]